Khamidullina, Zemfira,
Avzaletdinova, Diana,
Gareeva, Diana,
Morugova, Tatyana,
Lakman, Irina,
Kopp, Kristen,
Fiedler, Lukas,
Motloch, Lukas J.,
Zagidullin, Naufal (2024) to the absence/presence of T2D, with 2082 (84.1%) patients in the
control COVID-19 group and 381 (15.5%) in the T
Galimova, E.F.,
Gromenko, I.D.,
Gilyazova, I.R.,
Gromenko, D.D.,
Galimov, K.Sh.,
Abdeeva, G.R.,
Gromenko, Yu.Yu.,
Khusnutdinova, E.K.,
Galimov, Sh.N. (2024) male infertility (n = 30), the
control group included couples with female infertility of tubal origin
Urakov, Aleksandr,
Urakova, Natalya,
Samorodov, Aleksandr,
Shabanov, Petr,
Yagudin, Ilnur,
Stolyarenko, Anastasia,
Suntsova, Darya,
Muhutdinov, Nikita (2024) complications. As the current standard for drug quality
control does not include an assessment of the local
to that in the
control group. Results showed that daily intraperitoneal administration of DHMEQ at a dose of 14 mg
.01, respectively) and in one CpG site in women (U = 537, p = 0.03) with primary OP compared with
control